Trial Profile
Efficacy Study of Fluzone High-Dose Vaccine Compared With Fluzone Vaccine In Elderly Adults
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Aug 2015
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Sanofi; Sanofi Pasteur
- 03 Aug 2015 Findings of a supplementary analysis of this trial were published in Vaccine, according to a Sanofi Pasteur media release.
- 14 Aug 2014 Results published in the New England Journal of Medicine.
- 13 Aug 2014 Results have been published in the New England Journal of Medicine, according to a Sanofi Pasteur media release, which also reports results.